Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Tacrolimus × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Myelodysplastic Syndromes 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Hematologic Neoplasms 5 Primary Myelofibrosis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Hematologic Diseases 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Graft vs Host Disease 2

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡